Genesis Healthcare (GEN) – Company Press Releases
-
Swipe Right on Safety: New Study from Norton Finds 64% of Online Daters are Interested in Using AI as a Dating Coach
-
Gen to Announce Fiscal 2024 Fourth Quarter and Full-Year Results on May 9, 2024
-
Gen Brands Norton, Avast, AVG and Avira Earn 16 Award Recognitions Across Third-Party Testing Institutions AV-Comparatives and AV Test
-
Avast Continues Expansion of its Avast One Family of Products Adding Personalized, Modular Cyber Safety
-
Tax Prep Service Scams Rank High on Taxpayers' List of Concerns This Filing Season
-
Genmab Announces Initiation of Share Buy-Back Program
-
Genmab Publishes 2023 Annual Report
-
Avast Blocks Record Breaking 10 Billion Attacks in 2023, Nearly a 50% Increase from Previous Year
-
Gen Reports 18th Consecutive Quarter of Growth in Q3 FY24
-
ReputationDefender Releases Total Radius to Help Protect People From Physical and Online Threats
-
Norton Partners with Award-Winning Creator Dan Levy to Bring Real-Time Scam Detection App, Norton Genie, to the Masses
-
Gen to Announce Fiscal 2024 Third Quarter Results on February 1, 2024
-
ZNet Technologies Partners with Avast for the Cyber Safety of Small Businesses in India
-
Gen Reveals Cybersecurity Predictions for 2024
-
Avast Blocks All-Time High of 1 Billion Unique Cyber Attacks Per Month
-
Seekr Announces Secure Browser
-
Norton Declares November 26 "Cyber Safety Sunday," Advocating for Safe, Scam-Free Online Holiday Shopping
-
Major Shareholder Announcement
-
Genmab Announces Financial Results for the First Nine Months of 2023
-
Gen Reports Q2 FY24 Results and Confirms Annual Guidance Within Range
-
Tis the Season for Scams: New Study Shows Scammed Holiday Shoppers Lost $1500 on Average Last Year
-
Norton Boosts Security and Privacy with Enhanced Password Manager and AntiTrack
-
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2023
-
Gen to Release Fiscal 2024 Second Quarter Results and Host 1st Anniversary Investor Update on November 7, 2023
-
SimpliSafe® Strengthens its Home Protection Offering by Partnering with LifeLock™ to Help Stop Identity Theft
-
Norton Introduces New Small Business Solution with 24/7 Triple-Lock Cybersecurity for Small Teams
-
Norton Launches Secure Browser for Windows PC and Mac
-
Norton Consumer Cyber Safety Pulse Report: A Look at the Most Common Online Scams in 2023
-
Norton Preps Parents with Crash Course in Best Back-to-School Practices
-
Gen Reports 16th Consecutive Quarter of Growth in Q1 FY24
-
Genmab Announces Financial Results for the First Half of 2023
-
Driving Real Impact Around the World: Gen Releases 2023 Social Impact Report
-
Genmab Updates 2023 Financial Guidance
-
Introducing Norton Genie - Real-Time AI-powered Scam Detection at Your Fingertips
-
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2023
-
Gen to Announce Fiscal 2024 First Quarter Results on August 3, 2023
-
Fact or Phictionary? Norton Releases Phishing Dictionary to Help People Identify Scams
-
EPKINLY™ (epcoritamab-bysp) Approved by U.S. Food and Drug Administration as the First and Only Bispecific Antibody to Treat Adults with Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (D
-
Gen Delivers Fourth Consecutive Year of Organic Growth in FY23
-
Genmab Announces Financial Results for the First Quarter of 2023
-
Genmab To File Appeal in Its Second Arbitration Under License Agreement with Janssen
-
Genmab Announces Initial Resolution of Its Second Arbitration Under License Agreement with Janssen
-
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2023
-
Genmab and argenx Enter Partnership to Advance Antibody Therapies in Immunology and Oncology
-
Gen to Announce Fiscal 2023 Fourth Quarter and Full-Year Results on May 11, 2023
-
Norton and Avast Win SE Labs Awards for Excellent Performance
-
Gen Named One of America's Most Trustworthy Companies by Newsweek
-
Stalkerware Grows 239% Worldwide Over the Past Three Years
-
Avast Introduces Avast One Platinum
-
LifeLock Empowers Taxpayers with Knowledge to Help Fight Fraud
Back to GEN Stock Lookup